CRISPR Therapeutics
CRSP
CRSP
256 hedge funds and large institutions have $1.51B invested in CRISPR Therapeutics in 2020 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 97 increasing their positions, 54 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
256
Holders Change
+3
Holders Change %
+1.19%
% of All Funds
5.65%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
49
Increased
97
Reduced
54
Closed
44
Calls
$41.5M
Puts
$31.8M
Net Calls
+$9.67M
Net Calls Change
+$12.2M
Top Buyers
Top Sellers
1 |
Millennium Management
New York
|
$0 |
2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
$26.7M |
3 |
Two Sigma Investments
New York
|
$9.73M |
4 |
O
OrbiMed
New York
|
$23.4M |
5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
$45.7M |